🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The trial is designed as a multi-center, open label Phase 2 trial that inve...
Status
Completed
Location
3203; Antwerp University Hospital; Department of Medical Oncology
Start Date
2011-07
Trial ID
NCT01417936
Treatments Being Tested
Leptomeningeal metastasis (LM) is a devastating and terminal complication o...
Status
Unknown
Location
Multiple Locations
Start Date
2019-11-01
Trial ID
NCT04148898
Treatments Being Tested
This study was originally designed as a Phase III randomized, double blind,...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2005-12-13
Trial ID
NCT00272987
Treatments Being Tested
To seek the efficacy signals of trastuzumab in combination with chemotherap...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2017-07-01
Trial ID
NCT03185988
The purpose of this study is to determine if a new drug, RO4929097, can wor...
Status
Terminated
Location
Vanderbilt University/Ingram Cancer Center
Start Date
2010-09
Trial ID
NCT01198535
The purpose of this study is to evaluate the effectiveness of anti-HER2 the...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2020-07-01
Trial ID
NCT04337658
Treatments Being Tested
This randomized phase II trial studies how well erlotinib hydrochloride (Ta...
Status
Completed
Location
UC San Diego Moores Cancer Center
Start Date
2012-03-16
Trial ID
NCT01532089
Treatments Being Tested
The purpose of this study is to investigate the activity of panitumumab in ...
Status
Terminated
Location
Institute Jules Bordet
Start Date
2009-09
Trial ID
NCT00973193
Treatments Being Tested
This is an open-label, parallel designed study to assess the pharmacokineti...
Status
Unknown
Location
Sir Run Run Shaw Hospital
Start Date
2017-11-15
Trial ID
NCT03356158
Treatment, In combination with BSC, Open-label, Single arm, Efficacy Study....
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2008-01
Trial ID
NCT00542308
Treatments Being Tested